Detalles de la búsqueda
1.
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI.
Am Heart J
; 265: 153-160, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572785
2.
Independence of clinical events committees: A consensus statement from clinical research organizations.
Am Heart J
; 248: 120-129, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296411
3.
Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients.
Catheter Cardiovasc Interv
; 99(3): 896-903, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34505737
4.
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).
Eur Heart J
; 40(25): 2070-2085, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29992264
5.
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
Circulation
; 137(24): 2635-2650, 2018 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29891620
6.
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.
Lancet
; 392(10151): 940-949, 2018 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30166073
7.
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
Eur Heart J
; 39(23): 2192-2207, 2018 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29897428
8.
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.
Eur Heart J
; 39(19): 1687-1697, 2018 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28171522
9.
Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
Am Heart J
; 200: 110-117, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29898838
10.
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review.
Cardiovasc Revasc Med
; 59: 99-108, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657950
11.
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.
JAMA Cardiol
; 9(5): 437-448, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38506796
12.
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
Lancet
; 380(9851): 1396-405, 2012 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22951082
13.
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
J Am Coll Cardiol
; 81(6): 537-552, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754514
14.
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
J Am Coll Cardiol
; 82(2): 89-105, 2023 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37407118
15.
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial.
J Am Heart Assoc
; 11(10): e024291, 2022 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35229616
16.
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.
Eur Heart J Cardiovasc Pharmacother
; 8(1): 28-38, 2022 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32941620
17.
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.
Lancet
; 375(9710): 201-9, 2010 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20060578
18.
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
BMJ
; 373: n1332, 2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135011
19.
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.
Circ Cardiovasc Qual Outcomes
; 14(2): e006581, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33535773
20.
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.
JACC Cardiovasc Interv
; 14(4): 444-456, 2021 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602441